Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Mar 2019

Issa Amalia M, Thorogood Adrian, Joly Yann, Knoppers Bartha M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Approval
Share to Mutation
Share to Precision Medicine
Share to United States

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to United States Food and Drug Administration

Source

Open in PubMed Open full text

Identifiers

PMID: 29988078
DOI: 10.1038/s41436-018-0099-0
PMCID: PMC6752286

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations.PMID 29988078Read ↗

Mutation matters in precision medicine: A future to believe inSemantic proximity Read ↗

Precision Medicine and Rare Genetic Variants.Semantic proximity Read ↗

From genomic medicine to precision medicine: highlights of 2015Semantic proximity Read ↗

Pharmacogenomics: time to rethink its role in precision medicine.Semantic proximity Read ↗

From mutation identification to therapy: discovery and origins of the first approved gene therapy in the Western world.Semantic proximity Read ↗

Precision medicine with MET exon 14: a partial success.Semantic proximity Read ↗

Precision medicine in rare diseases: What is next?Semantic proximity Read ↗

Towards precision medicine.Semantic proximity Read ↗

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trialsSemantic proximity Read ↗

Milestones of Precision Medicine: An Innovative, Multidisciplinary OverviewSemantic proximity Read ↗

Genetics, Genomics, and Precision Medicine.Semantic proximity Read ↗

Next-Generation sequencing transforming clinical practice and precision medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.